Skip to main content
GANX logo

GANX

Gain Therapeutics, Inc.
$1.91 -0.08 (-4.02%) At close · Jul 2
Market Cap
$81.47M
Shares
42,654,038

Fails to deliver — shares from a trade that were not delivered to the buyer by the settlement date — published by the SEC twice a month. Persistent fails can reflect settlement problems or naked short selling.

Fails to Deliver History

Settlement Date Quantity Price Value
2026-06-11 106 $1.64 $174
2026-06-10 200,220 $1.65 $330,363
2026-06-09 9,452 $1.69 $15,974
2026-06-05 7,038 $1.86 $13,091
2026-06-03 90,967 $1.83 $166,470
2026-05-21 3,000 $1.65 $4,950
2026-05-20 62 $1.59 $99
2026-05-19 3,066 $1.62 $4,967
2026-04-28 6,290 $1.95 $12,266
2026-04-27 42,425 $1.97 $83,577
2026-04-24 24 $1.89 $45
2026-04-20 1,536 $2.13 $3,272
2026-04-16 1,700 $2.14 $3,638
2026-04-14 83 $1.87 $155
2026-04-13 15,915 $1.80 $28,647
2026-04-10 21,376 $1.84 $39,332
2026-04-08 1,361 $1.85 $2,518
Showing 1–17 of 17 settlements
Key facts CIK 1819411 CUSIP 36269B105 Visit website Investor relations